Featured Research

from universities, journals, and other organizations

Study points to way of improving chemotherapy response

Date:
September 8, 2011
Source:
University of Oxford
Summary:
Blocking key proteins could improve response to a common chemotherapy drug, suggests a new study which used cancer cells grown in the lab.

Paclitaxel blocks cancer growth by stopping cells separating into two new cells.
Credit: Image courtesy of University of Oxford

Blocking key proteins could improve response to a common chemotherapy drug, suggests an Oxford University-led study which used cancer cells grown in the lab.

Related Articles


The research offers several new targets for developing future drugs to boost the success rate of the tumour-shrinking drug paclitaxel (Taxol).

Paclitaxel is a chemotherapy drug commonly used to treat breast and ovarian cancer, but some tumours can become resistant over time and start growing again. The drug blocks the growth of cancer by interfering with microtubules -- structures that help chromosomes to separate during cell division.

The international team of researchers found that blocking certain proteins stabilised the microtubules and made ovarian cancer cells more sensitive to paclitaxel. The findings are published in the journal Cancer Research.

Lead researcher Dr Ahmed Ahmed of the University of Oxford said: 'Our work provides further evidence for the important link between the stability of microtubules, the backbone of the cell, and sensitivity to paclitaxel.

'And because the proteins we've identified share the same target as paclitaxel, it raises the prospect of developing more specific drugs that sensitise cancer cells to paclitaxel without damaging the surrounding tissues.'

Previous research by Dr Ahmed and colleagues in the Nuffield Department of Obstetrics and Gynaecology found that the loss of a protein called TGFBI -- which sends messages that stabilise the microtubules -- caused paclitaxel to fail.

So to test the theory that microtubule stability may be essential for paclitaxel response, the researchers systematically blocked other signalling proteins in ovarian cancer cells growing in the lab, to see which might alter paclitaxel response.

Dr Robert Bast of the University of Texas MD Anderson Cancer Centre, who was also involved in the work, said: 'Our study has revealed several new proteins involved in microtubule stability that could be potential targets for drugs to improve the sensitivity of cancer cells to paclitaxel, without damaging healthy cells.'

The research was funded by Cancer Research UK, the University of Oxford, the Camilla Samuel Fund, and the MD Anderson Cancer Center.

Dr Julie Sharp, senior science information manager at Cancer Research UK, said: 'Overcoming drug resistance is a key challenge for our researchers. Unravelling the genetic basis of cancer to find out what determines whether a patient will respond to treatment will help us take a more targeted approach to tackle this problem. This approach could lead to fewer side effects and provide a lifeline for patients who have stopped responding to conventional treatments.'


Story Source:

The above story is based on materials provided by University of Oxford. Note: Materials may be edited for content and length.


Journal Reference:

  1. A. A. Ahmed, X. Wang, Z. Lu, J. Goldsmith, X.-F. Le, G. Grandjean, G. Bartholomeusz, B. Broom, R. C. Bast. Modulating Microtubule Stability Enhances the Cytotoxic Response of Cancer Cells to Paclitaxel. Cancer Research, 2011; 71 (17): 5806 DOI: 10.1158/0008-5472.CAN-11-0025

Cite This Page:

University of Oxford. "Study points to way of improving chemotherapy response." ScienceDaily. ScienceDaily, 8 September 2011. <www.sciencedaily.com/releases/2011/09/110903101656.htm>.
University of Oxford. (2011, September 8). Study points to way of improving chemotherapy response. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2011/09/110903101656.htm
University of Oxford. "Study points to way of improving chemotherapy response." ScienceDaily. www.sciencedaily.com/releases/2011/09/110903101656.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins